SCHEMBL4596403

SCHEMBL4596403

Clc1ccccc1-c1cccc2c1OC(CCc1ccccc1)C2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT2 Q8IXJ6 2/20 0.48
CYP3A4 P08684 2/20 0.40
AQP1 P29972 1/20 0.38
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38
SLC6A3 Q01959 1/20 0.38
PRKAB2 O43741 1/20 0.37
PRKAG1 P54619 1/20 0.37
PRKAA2 P54646 1/20 0.37
PRKAA1 Q13131 1/20 0.37
PRKAG3 Q9UGI9 1/20 0.37
PRKAG2 Q9UGJ0 1/20 0.37
PRKAB1 Q9Y478 1/20 0.37
DRD4 P21917 3/20 0.36
MAOB P27338 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
HTR1A P08908 1/20 0.35
HTR7 P34969 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6047946 0.92 SIRT2 (0.46) SIRT2CYP3A4AQP1SLC6A2SLC6A4
SCHEMBL4596679 0.91 SIRT2 (0.50) SIRT2CYP3A4AQP1SLC6A2SLC6A4
SCHEMBL4596777 0.89 SIRT2 (0.49) SIRT2CYP3A4AQP1PRKAB2PRKAG1
SCHEMBL4596728 0.89 SIRT2 (0.52) SIRT2CYP3A4AQP1PRKAB2PRKAG1
SCHEMBL4595085 0.86 SIRT2 (0.54) SIRT2CYP3A4AQP1PRKAB2PRKAG1
SCHEMBL6047969 0.85 CYP3A4 (0.44) SIRT2CYP3A4SLC6A2SLC6A4SLC6A3
SCHEMBL4596535 0.81 PRKAB2 (0.47) SIRT2CYP3A4PRKAB2PRKAG1PRKAA2
SCHEMBL5794284 0.81 PRKAB2 (0.54) AQP1PRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL5794592 0.81 PRKAB2 (0.54) AQP1PRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL4219184 0.81 PRKAB2 (0.54) AQP1PRKAB2PRKAG1PRKAA2PRKAA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1874750-A1 DIHYDROBENZOFURANYL ALKANAMINE DERIVATIVES AS 5HT2C AGONISTS Wyeth Incoporated (US) 2008-01-09 EP disclosed